Stock Information
Eli Lilly and Co (LLY)
Ticker Symbol: LLY
Exchange: NYSE
Sector: Pharmaceuticals
Market Cap: $956,214,728,185.00 mil
Piotroski score: 8
PE Ratio: 55.3379
EPS (TTM): 20.449
Revenue (TTM): $66.11 M
Dividend Yield: 0.6420784%
ROE: 102.26%
Latest News
-
BME: Attractive Discount With Steady Monthly Distribution
Sun, Dec 28, 2025 9:39 PM
-
Chevron, Kimberly-Clark Among 16 Companies To Kick Off 2026 With Annual Dividend Increases In January
Fri, Dec 26, 2025 10:35 PM
-
Oral Wegovy Approval Is The Critical 2026 Lifeline Novo Nordisk Needs
Fri, Dec 26, 2025 2:18 PM
-
Can Amgen Sustain Its Rally In 2026
Fri, Dec 26, 2025 1:03 PM
-
Lilly and Novo Cut GLP-1 Prices as Pill Approvals Expand Access
Fri, Dec 26, 2025 1:01 PM
-
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly
Fri, Dec 26, 2025 4:55 AM
-
Is Eli Lilly Pulling Ahead in the Weight Loss Drug Battle?
Thu, Dec 25, 2025 5:05 PM
-
As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock?
Thu, Dec 25, 2025 2:00 PM
-
Novo, Lilly race to cement lead in India’s obesity drug market, Reuters says
Thu, Dec 25, 2025 11:40 AM
-
Viking Therapeutics (VKTX) Is Up 8.9% After Rival Data Bolsters Its Oral Obesity Program
Thu, Dec 25, 2025 11:08 AM
Key Financials
Financial data not available
